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Abstract: Smallanthus sonchifolius (Poepp.) H. Rob., Asteraceae, known as yacon, 
is an herb that is traditionally used for the treatment of diabetes in folk medicine. 
However, recent studies have demonstrated that this plant has other interesting 
properties such as anti-microbial and anti-infl ammatory actions. Thus, the purpose of 
this study was to evaluate the topical anti-infl ammatory property of different extracts 
prepared from yacon leaves and analyze the role of different chemical classes in this 
activity. Three yacon leaf extracts were obtained: aqueous extract, where chlorogenic 
acid derivatives and sesquiterpene lactones were detected; leaf rinse extract, rich in 
sesquiterpene lactones; and polar extract, rich in chlorogenic acid derivatives. All 
the extracts exhibited anti-edematogenic activity in vivo (aqueous extract: 25.9% 
edema inhibition at 0.50 mg/ear; polar extract: 42.7% inhibition at 0.25 mg/ear; and 
leaf rinse extract: 44.1% inhibition at 0.25 mg/ear). The leaf rinse extract furnished 
the best results regarding neutrophil migration inhibition, and NO, TNF-α and PGE2 
inhibition. These data indicate that both sesquiterpene lactones and chlorogenic acid 
derivatives contribute to the anti-infl ammatory action, although sesquiterpene lactones 
seem to have more pronounced effects. In conclusion, yacon leaf extracts, particularly 
the sesquiterpene lactone-rich extract, has potential use as topical anti-infl ammatory 
agent.
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Introduction
 Smallanthus sonchifolius (Poepp.) H. Rob., 
popularly known as yacon, is a medicinal herb belonging 
to the Asteraceae family. It is native to the Andean region, 
where its tuberous roots, rich in inulin, are consumed as 
food (Goto et al., 1995; Pedreschi et al., 2003; Genta et 
al., 2005). Yacon cultivation has been expanded to several 
countries such as Japan, New Zealand, Czech Republic, 
and Brazil (Vilhena et al., 2000; Genta et al., 2010), and 
its leaves are used in folk medicine for the treatment of 
hyperglycemia as well as kidney and skin disorders (Goto 
et al., 1995; Pedreschi et al., 2003; Genta et al., 2005). 
 The hypoglycemic activity of different yacon 
leaf extracts has been investigated in normal and diabetic 
animals (Aybar et al., 2001; Miura et al., 2004; Miura, 2007; 
Baroni et al., 2008; Genta et al., 2010). In these studies, 
administration of polar extracts resulted in signifi cant 
hypoglycemic effect. Further investigations showed that 
organic fractions of the foliar extracts have in vitro anti-
oxidant activity and diminished glucose production in rat 
hepatocytes (Valentová et al., 2005). This anti-oxidant 
action has been attributed to the presence of higher 
concentrations of phenolic compounds such as chlorogenic 
acid and other caffeic acid derivatives in yacon leaves (Yan 
et al., 1999; Simonowska, et al., 2003; Takenaka et al., 
2003; Valentová & Ulrichová, 2003; Valentová et al., 2004; 
2005). The existence of several chlorogenic acid derivatives 
(CGA) such as 3,4-dicaffeoylquinic, 3,5-dicaffeoylquinic, 
4,5-dicaffeoylquinic, 2,3,5-tricaffeoylaltraric, and 2,4,5-
tricaffeoylaltraric acids has been described in yacon leaves 
and roots (Takenaka et al., 2003; Terada et al., 2009). The 
two altraric acids isolated from yacon leaves elicit potent 
inhibition of the enzyme α-glucosidase, and a patent for 
these compounds as oral hypoglycemic agents has been 
fi led (Takenaka et al., 2003).
 Additional studies have demonstrated that yacon 
display other interesting properties such as anti-fungal, 
antibacterial, and anti-infl ammatory actions (Inoue et al., 
1995; Pinto et al., 2001; Gonçalez et al., 2003; Lin et al., 
2003; Pak et al., 2006; Schorr et al., 2007). These activities 
have been associated with the presence of sesquiterpene 
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lactones (STL) (Lin et al., 2003; Pak et al., 2006), which 
are present in higher concentrations in the leaves (Inoue et 
al., 1995; Schorr & Da Costa, 2003). Enhydrin, uvedalin, 
sonchifolin, and polimatin B are the main STL identified 
in yacon leaves (Schorr et al., 2007). Some of these STL, 
such as enhydrin and uvedalin, have been shown to exhibit 
anti-inflammatory activity through inhibition of the NF-
κB transcription factor (Schorr et al., 2007; Siedle et al., 
2004).
 Although several biological activities have been 
reported for yacon leaf extracts, it has been recently 
demonstrated that the chronic oral consumption of aqueous 
yacon leaf extract is toxic to rats, culminating in kidney 
damage (Oliveira et al., 2011). The phytochemical analysis 
of this aqueous extract revealed that it contains both STL 
and CGA. In this same study, treatment with an STL-rich 
extract was compared with treatment using a CGA-rich 
extract. It was found that toxicity is due to the presence of 
STL, while the extract rich in CGA is safer. 
 Both STL and CGA have been described as anti-
inflammatory agents in the literature (Shin et al., 2004; 
Siedle et al., 2004; Santos et al., 2006; Schorr et al., 2007), 
and yacon leaf extracts may be a promising therapeutic 
agent in topical applications. Thus, the aim of this work was 
to compare the effect of three different yacon leaf extracts 
using a topical model of anti-inflammatory activity as well 
as in vitro assays, in order to gain insight into the classes 
of compounds present in these extracts and the mode of 
action involved in their activities.
Materials and Methods 
Plant material
 Smallanthus sonchifolius (Poepp.) H. Rob., 
Asteraceae, leaves were collected in a cultivated area of 
the university campus of Ribeirão Preto, University of Sao 
Paulo, SP, Brazil. Intact leaves were air-dried at 40 °C, and 
a voucher specimen was deposited at the SPFR herbarium 
of the same university under the code R.B. Oliveira 495. 
The identification was confirmed by R.B. Oliveira.
Chemicals and drugs
 Analytical grade MeOH and acetone (Dinamica) 
were employed for preparation of the extracts. Glacial 
acetic acid, acetonitrile (Merck), and ultra-pure water 
(Millipore) were HPLC grade. Chlorogenic acid (95% of 
purity) and quercetin (95% of purity) (Sigma-Aldrich), 
as well as enhydrin (96% of purity by HPLC analyses) 
available in our laboratory (Schorr & Da Costa, 2003; 
Schorr et al., 2007) were utilized as HPLC standards. The 
following drugs were used for the anti-inflammatory tests: 
acetone (Dinamica), croton oil (Sigma), glycerol (Synth), 
indomethacin (99% of purity) (Sigma), dexamethasone 
(0.001 g in 1.0 g of vehicle, Medley), Cremophor® EL 
(Basf), hexadecyltrimethyl ammonium bromide (HTAB) 
(Sigma), TMB substrate reagent (BD-OptEIATM), 
DEMEM (Gibco), gentamicin (Gibco), bovine serum 
(Gibco), sulfanilamide (Sigma), N-(1-naphthyl)
ethylenediamine (Sigma), and PGE2 (Invitrogen) and 
TNF-α (Invitrogen) ELISA Kits.
Extract preparation
 Three extracts from air-dried yacon leaves were 
prepared as described previously (Oliveira et al., 2011). 
Briefly, the aqueous extract (AE) was obtained from 500 
g of dried intact leaves. These leaves were divided in 24 
portions of 20 g. In each portion of 20 g was added 1,000 
mL of boiling water. The resulting extracts were cooled 
at room temperature (ca. 26 °C), filtered, lyophilized, 
and frozen at -20 °C until the experiment was conducted 
(total yield 45 g residue). The leaf-rinse extract (LRE) was 
produced by rinsing 1 kg of dried yacon leaves with acetone 
for 10 s, which furnished an extract rich in STL (STL are 
present in glandular trichomes on the leaf surface). This 
extract was then filtered, and the solvent was evaporated 
under vacuum. The solid material was re-suspended with 
MeOH-H2O (7:3, v/v) and submitted to liquid-liquid 
partition with n-hexane. The hydroalcoholic fraction was 
evaporated under vacuum, lyophilized, and frozen at -20 
°C (total yield 26.9 g) until the assay was performed. 
The polar extract (PE) was prepared with powdered air-
dried yacon leaves previously rinsed in acetone (LRE 
preparation). Extraction was carried out by three 24-h 
maceration procedures with 70% MeOH. The extract was 
filtered, the solvent was evaporated under vacuum, and 
the sample was submitted to liquid-liquid partition with 
n-hexane. The hydroalcoholic fraction was dried under 
vacuum, lyophilized, and frozen at -20 °C (total yield 95 
g) until the experiment was accomplished.
Quantification of major compounds
 Phytochemical analysis of the three extracts was 
carried out by reversed-phase HPLC-UV-DAD profiling 
as described previously (Oliveira et al., 2011). For the 
quantification procedure, the HPLC system consisted of 
a Shimadzu SCL 10Avp liquid chromatograph equipped 
with a Shimadzu SPD-M10Avp photodiode array detector-
DAD and a C-18 column (Shimadzu, ODS Shim-pack 5 
µm, 4.6 x 250 mm). Elution was conducted in the following 
way: initial gradient elution with a binary mobile phase 
consisting of H2O (0.5% AcOH) and MeCN (0.5% AcOH) 
in a linear gradient of 0 to 5% MeCN for 30 min, followed 
by isocratic elution with 45% MeCN from 30 to 50 min 
and final linear gradient of 45 to 100% MeCN from 50 to 
80 min. The flow rate was 1.3 mL/min, and the injection 
volume was 20 µL. The UV data were acquired between 
Topical anti-inflammatory activity of yacon leaf extracts 
Rejane B. Oliveira et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 23(3): May/Jun. 2013 499
190 and 600 nm, and chromatograms were simultaneously 
recorded at 254 and 325 nm. The chromatographic data 
were processed using Class VP software (version 5.02; 
Shimadzu).
 Quantifications were performed by using standard 
curves of enhydrin to STL, chlorogenic acid to CGA, 
and quercetin to flavonoids. The standard solutions were 
injected by means of an automatic injector, in triplicate. 
The concentrations were obtained by serial dilutions of 
35.25-0.24 µg/mL for chlorogenic acid and quercetin, and 
2,000-15.63 µg/mL for enhydrin, in a total of eight points 
for each curve. The peak areas were used for calculation of 
the concentration of the compounds in each extract using 
the obtained equations and by comparison of their UV 
spectra at 254 nm.
Animals
 Adult male Balb/c mice (20-25 g) were provided 
by the animal housing facility of Faculdade de Ciências 
Farmacêuticas de Ribeirão Preto, USP, and were 
maintained under standard laboratory conditions (25±2 °C 
at 40-60% relative humidity and 12-h light-dark cycle). 
The animals were allowed free access to food and water. 
All the animals were euthanized in a CO2 chamber. The 
study was approved on August 1, 2007 by the Institutional 
Ethical Animal Committee of the University of Sao Paulo 
(protocol number: 07.1.636.53.5), which followed the rules 
of the Brazilian Committee on Animal Care (COBEA).
Croton oil-induced mouse ear edema
 Topical anti-inflammatory activity was evaluated 
as the inhibition of the croton oil-induced ear edema in 
mice, using a methodology modified from Tubaro et al. 
(1985). Briefly, cutaneous inflammation was induced 
by application of 20 μL acetone solution containing 5% 
irritant croton oil on the inner surface of the left ear of 
the mouse (n = 6 per group). The right ears remained 
untreated. The target leaf extracts (0.125, 0.25, and 0.5 
mg/ear) dissolved in glycerol were topically applied in 
the inner surface of the left ears 30 min after croton oil 
administration. Indomethacin (0.5 mg/ear) was used as 
reference compound, and control animals received irritant 
and vehicle only. The vehicle was acetone-glycerol (1:8, 
v/v) for LRE, indomethacin, and control; and water-
glycerol (1:8, v/v) for AE, PE, and control. The mice were 
euthanized six h later, and a six-mm diameter plug was 
removed from both the treated and untreated ears with 
the aid of a dermatologic punch. The edematous response 
was measured as the weight difference between the two 
plugs. The anti-inflammatory activity was expressed as the 
percentage of edema reduction in treated mice as compared 
to control mice.
Myeloperoxidase assay
 The myeloperoxidase (MPO) kinetic-
colorimetric assay was used for evaluation of leukocyte 
migration to the subcutaneous tissue of mouse ears. Left 
ear plugs obtained from the croton oil ear edema assay 
(see above) were kept in 200 μL NaEDTA/NaCl buffer 
(pH 4.7) at -20 ºC until the experiment was initiated. The 
plugs were homogenized with Polytron (PT03100) and 
centrifuged at 956 x g for 15 min, at 4 ºC. The pellet was 
re-suspended in 200 μL hexadecyltrimethyl ammonium 
bromide (HTAB) 0.5% buffer (pH 5.4) and homogenized 
again. The samples were re-centrifuged, and 20 μL 
supernatant was employed for MPO quantification. 
MPO was quantified by using 20 μL supernatant mixed 
with 30 μL NaPO4 0.08 M. The enzymatic reaction was 
assessed with 50 μL TMB substrate reagent. After 10 
min, the reactions were stopped with H2SO4 (2.5 M). The 
absorbance was measured at 450 nm (Bio-Rad model 680 
- Microplate Reader, Brazil), and the MPO activity in the 
samples was compared to a standard curve of neutrophils. 
The results are presented as the MPO activity (O.D./mg 
of tissue).
In vitro anti-inflammatory activity
 Murine macrophages of the RAW 264.7 cell 
lineage were cultivated at 37 °C and 5% CO2 in DEMEM 
(Dulbecco’s Modified Eagle Medium) supplemented with 
10% bovine serum and gentamicin. The cells were gently 
detached from the bottle with cell scrapes, transferred to 
50-mL tubes, and centrifuged for 10 min at 264 x g and 18 
°C. The supernatant was discarded, and the cells pellet was 
re-suspended in 10 mL DEMEM. The cell concentration 
was adjusted to 5 x 105 cells/mL, and the cells were 
placed into 96-well plates at 37 °C for 24 h, to allow for 
cell adhesion. The medium was then substituted with 100 
µL medium containing the yacon leaf extracts at different 
concentrations (0.25, 0.5, and 1.0 µg/mL), as previously 
determined by means of the MTT viability cell assay, or 
the positive controls indomethacin or dexamethasone (1.0 
µg/mL). Three independent experiments were conducted. 
Each independent experiment was performed in triplicate. 
After two hours, the cells were stimulated with LPS 
(lipopolysaccharide from E. coli 0111.B4 cellular wall) at 
2 µg/mL. The cells were incubated for 24 h at 37 °C and 
5% CO2. The supernatants were employed for NO (nitric 
oxide), TNF-α, and PGE2 quantification. 
NO, TNF-α, and PGE2
 NO was quantified by using supernatants from 
the RAW 264.7 cell culture. To this end, an aliquot of 
100 µL supernatant was incubated with an equal volume 
of Griess reagent (1:1 v/v 5% H3PO4 containing 1% 
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sulfanilamide and N-(l-naphthyl)ethylenediamine 1%) for 
5 min. Absorbance was measured at 550 nm, and the total 
nitrite concentration was determined by comparison with 
a standard NaNO2 curve. The remaining supernatants from 
the RAW 264.7 culture were used for TNF-α and PGE2 
quantification by means of ELISA commercial kits, using 
the manufacturer's instructions. The results were compared 
with standard curves and are expressed in pg/mL.
Statistical analysis
 Data are represented as mean±SEM. Results 
were analyzed by one-way ANOVA followed by Tukey's 
multiple comparison test.
Results
 The HPLC-UV-DAD phytochemical profiles 
of the extracts AE, PE, and LRE have been published 
previously (Oliveira et al., 2011). Polar compounds 
related to chlorogenic acid were identified as the major 
components in AE and PE, whereas several STL and 
flavonoids were detected in LRE (Table 1). However, STL 
were also present in AE, albeit in smaller amounts. Herein, 
we have constructed analytical curves for enhydrin (r2 = 
0.992), chlorogenic acid (r2 = 0.999), and quercetin (r2 
= 0.996) during the quantification experiments. Table 1 
shows that LRE contains high STL concentrations and low 
concentrations of flavonoids [3-O-methylquercetin (5) and 
3,4’-di-O-methylquercetin (6)], while no CGA (1–4) is 
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Table 1. Concentrations (µg/mL) of the compounds present in the three yacon leaf extracts investigated in this work as obtained by 
HPLC-UV-DAD analytical curve.
Compound # Class Identified as AE PE LRE
(1) CGA coumaric acid 0.3 3.5 0.0
(2) CGA caffeic acid 0.3 1.3 0.0
(3) CGA *CGA1 2.0 9.9 0.0
(4) CGA *CGA2 1.3 9.6 0.0
(5) Flavonoid 3-O-methylquercetin 0.0 0.0 20.4
(6) Flavonoid 3,4’-di-O-methylquercetin 0.0 0.0 7.2
(7) STL enhydrin 99.7 0.0 1,997.7
(8) STL uvedalin 319.0 0.0 1,257.4
(9) STL polymatin B 129.3 0.0 616.2
(10) STL sonchifolin 102.7 0.0 519.1
The compounds were identified by comparison with authentic standards available in our laboratory. *Chemical structures unidentified. The UV profile 
suggests that these compounds correspond to CGA (UV max: 298 and 325 nm). CGA1 and CGA2 correspond to the most intense peaks in AE and PE 
at 325 nm. AE: aqueous extract, PE: polar extract, LRE: leaf-rinsed extract. 
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detected in this extract. The STL enhydrin (7), uvedalin 
(8), polymatin B (9) and sonchifolin (10) appear at lower 
concentrations in AE as compared to LRE, but their 
concentrations are still higher as compared to those of CGA 
in AE. PE, in turn, contains larger CGA concentrations as 
compared to AE, but this extract lacks STL.
 In the croton oil-induced ear edema assay, the 
topical treatment of the animals with AE led to reduction 
of the ear edema, but a statically significant response 
(25.9% edema inhibition) was only verified at the highest 
tested dose (0.5 mg/ear) (Figure 1A). This effect was 
statically similar to that elicited by indomethacin (28% 
edema inhibition). The topical effect of the extract PE was 
statically significant for all the assayed doses (25.2, 42.7, 
and 30.1 % ear edema inhibition for doses of 0.125, 0.25, 
and 0.5 mg/ear, respectively). Topical treatment with LRE 
showed statically significant outcome at all tested doses 
(0.125 mg/ear, 44.1% ear edema inhibition; 0.25 mg/ear, 
38.5% ear edema inhibition; and 0.5 mg/ear, 18.9% ear 
edema inhibition) (Figure 1A). 
 MPO activity was statically decreased as 
compared to the control group at all the investigated 
extract doses as well as in the presence of indomethacin 
(Figure 1B). All the extracts had a more marked influence 
on MPO than indomethacin (0.5 mg/ear, 2.34 O.D./mg 
of tissue). Meanwhile, PE (0.5 mg/ear, 0.35 O.D./mg of 
tissue) and LRE (0.5 mg/ear, 0.30 O.D./mg of tissue) had 
a more pronounced effect on MPO than AE (0.5 mg/ear, 
0.83 O.D./mg of tissue).
 Treatment of RAW 264.7 cells with AE and 
PE exercised no effect on NO production (Figure 2A). 
However, treatment of the cells with LRE resulted in a 
statistically dose-dependent inhibition of NO production 
(0.25 µg/mL: 23.2% inhibition; 0.5 µg/mL: 38.5% 
inhibition; 1.0 µg/mL: 72.96 % inhibition). The LRE 
activity at doses of 0.25 and 0.5 µg/mL was similar to the 
activity of the positive control dexamethasone (1.0 µg/mL: 
33.6% inhibition), whilst LRE activity at a dose of 1.0 µg/
mL was statistically higher than that of dexamethasone. 
Figure 1. Effect of the three yacon leaf extracts on the topical anti-inflammatory activity induced by croton oil. A. Weight of edema 
measured as the weight difference between the two plugs of left ear (with edema induction) and right ear (without edema induction). 
B. MPO activity in the ears with edema induction. Data are expressed as means±SEM. *p<0.05 in relation to the control (one-way 
ANOVA following Tukey’s multiple comparison test. AE: aqueous extract, PE: polar extract, LRE: leaf-rinsed extract.
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 All the extracts were able to moderately inhibit 
TNF-α production (Figure 2B), and treatment with LRE 
evidenced a dose-dependent trend (0.25 µg/mL: 33.25% 
inhibition; 0.5 µg/mL: 42.13% inhibition; 1.0 µg/mL: 
48.32% inhibition). LRE activity at a dose of 0.25 µg/mL 
was statistically similar to that of indomethacin (1.0 µg/
mL: 27.41% inhibition), while LRE at doses of 0.5 and 1.0 
µg/mL was more active than indomethacin (Figure 2B). 
AE (1.0 µg/mL: 38.42% inhibition) and PE (1.0 µg/mL: 
36.37% inhibition) led to statistically similar effects at all 
the tested doses (Figure 2B).
 In the same way, all the extracts were able to 
inhibit in vitro PGE2 production, being the actions of AE 
(1.0 µg/mL: 73.45% inhibition) and LRE (1.0 µg/mL: 
77.01% inhibition) more pronounced than that of PE (1.0 
µg/mL: 41.57% inhibition). Treatment with LRE was the 
only one that presented a dose-dependent effect on PGE2 
production (Figure 2 C). AE and LRE displayed activity 
that was statistically similar to that of indomethacin (1.0 
µg/mL: 79.11% inhibition).
Discussion
 As previously reported (Oliveira et al., 2011), 
HPLC analysis identified PE as a polar extract rich in 
CGA and lacking STL, LRE as an extract rich in STL and 
flavonoids, and AE as an extract containing both CGA and 
STL. Here, we have quantified the different classes of the 
main compounds in these three extracts. We verified that 
AE displays lower STL concentrations as compared to LRE. 
However, STL concentrations in AE are larger if compared 
to CGA concentrations in this same extract. This suggests 
that STL play an important role in the biological activities 
observed for the aqueous extracts that are used orally by 
the population (Oliveira et al., 2011). PE contains high 
CGA concentrations, while STL are the major compounds 
in LRE. Thus, we have achieved our goal, which was to 
produce an extract rich in CGA and another one rich in 
STL, in order to gain insight into the role of these two 
classes of compounds in the anti-inflammatory activity of 
yacon leaves.
Figure 2. In vitro anti-inflammatory assay in RAW 264.7 cells culture induced with LPS after treatment with the three different yacon 
leaf extracts. A. Nitric oxide determination. B. TNF-α determination. C. PGE2 determination. Data are expressed as mean±SEM. 
*p<0.05 in relation to the control without LPS. AE: aqueous extract, PE: polar extract, LRE: leaf-rinsed extract.
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that STL plays an important role in this activity. The effect 
of these extracts in decreased PGE2 levels can be related 
with their effect on inhibition of leukocyte migration as 
demonstrated in the MPO assay, since it was demonstrated 
that PGE2 production at the late phase in the TPA edema 
model depends on the infiltrated leukocytes, while TNF-α 
levels are not related to cell infiltration in this model 
(Murakawa et al., 2006). 
 Thus, our results have demonstrated that all 
the three tested yacon leaf extracts exhibit topical anti-
edematous activity in vivo. This activity may be a 
consequence of an anti-inflammatory action, as evidenced 
by the fact that all the assayed extracts exert some effect on 
inflammatory mediators. This suggests that both STL and 
CGA contribute to the observed responses. However, the 
LRE extract, which is rich in STL, has a more pronounced 
effect on the anti-inflammatory mediators. In conclusion, 
our observations suggest that yacon leaf extracts, especially 
the one rich in STL, has potential application as a topical 
anti-inflammatory agent.
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